Philip M. Laws

Chapeltown Road
Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Executive Summary: The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Executive Summary: The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: April 20, 2026

Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Journal: The British journal of dermatology

Published: February 24, 2026

Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.

Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.

Journal: The British journal of dermatology

Published: February 16, 2026

Serious infections in children and young people with psoriasis on systemic treatments.

Serious infections in children and young people with psoriasis on systemic treatments.

Journal: The British journal of dermatology

Published: February 11, 2026

Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Journal: The British journal of dermatology

Published: January 28, 2026

A cross-sectional survey of stakeholders to inform the update of the British Association of Dermatologists guidelines for the safe and effective prescribing of methotrexate in dermatology.

A cross-sectional survey of stakeholders to inform the update of the British Association of Dermatologists guidelines for the safe and effective prescribing of methotrexate in dermatology.

Journal: Clinical and experimental dermatology

Published: January 26, 2026

Comment on: FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan: reply.

Comment on: FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan: reply.

Journal: Rheumatology (Oxford, England)

Published: January 19, 2026

Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.

Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.

Journal: Psoriasis (Auckland, N.Z.)

Published: January 05, 2026

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: December 19, 2025

Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.

Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.

Journal: Dermatology and therapy

Published: November 24, 2025

Serious infection risk in people treated with infliximab for severe psoriasis.

Serious infection risk in people treated with infliximab for severe psoriasis.

Journal: The British journal of dermatology

Published: November 18, 2025

Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.

Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.

Journal: Annals of the rheumatic diseases

Published: November 12, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026